Dr Reddy's Laboratories (RDY) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Dr Reddy's Laboratories

· RDY

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

10.874 B

-1.79%

Dr Reddy's Laboratories (RDY) Company Statistics | The Fly

General

Market Cap: $10.87B
Enterprise Value: $1.09T
Shares Outstanding: 832,980,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 50.15%
Operating Margin: 10.57%
Net Profit Margin: 9.96%
FCF Margin: 4.55%
ROA: 5.75%
ROE: 8.88%
ROIC: 5.84%
Current Ratio: 1.90
Debt-to-Equity: 0.19
Revenue Per Employee: —

Valuation (TTM)

P/E: 31.01
PEG: 2.93
P/S: —
P/FCF: 69.84
P/B: —
EV/EBITDA: 16.32

Growth

Rev 1Y: 8.58%
Rev 1Y Fwd Est: -1.07%
Rev 3Y (CAGR): 12.86%
Rev 5Y (CAGR): 168.02%
Rev 10Y (CAGR): 8.61%
EPS 1Y: -20.44%
EPS 1Y Fwd Est: -21.27%
EPS 3Y (CAGR)

Income Statement (TTM)

Revenue: $3.47B
Gross Margin: 50.15%
Operating Expenses: $1.37B
Operating Income: $366.6M
Net Profit: $345.46M

Balance Sheet

-0.15%

EPS 5Y (CAGR)

21.07%

EPS 10Y (CAGR)

-7.45%

Cash and Equivalents: $116.7M
Working Capital: $1.48B
Total Assets: $5.99B
Net Debt: $632.75M
Total Liabilities: $1.96B
Total Equity: $4.03B

Cash Flow Statement (TTM)

Cash Flow from Operations: $426.97M
Cash Flow from Investing: -$460.61M
Cash Flow from Financing: $42.45M
Free Cash Flow: $157.76M
Capital Expenditures: $269.21M